These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 31425167

  • 21. Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging.
    Dodds TJ, Lo S, Jackett L, Nieweg O, Thompson JF, Scolyer RA.
    Am J Surg Pathol; 2018 Mar; 42(3):359-366. PubMed ID: 29240580
    [Abstract] [Full Text] [Related]

  • 22. Micrometastasis of a sentinel lymph node in cutaneous melanoma is a significant prognostic factor for disease-free survival, distant-metastasis-free survival, and overall survival.
    Moehrle M, Schippert W, Rassner G, Garbe C, Breuninger H.
    Dermatol Surg; 2004 Oct; 30(10):1319-28. PubMed ID: 15458529
    [Abstract] [Full Text] [Related]

  • 23. Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study.
    Tejera-Vaquerizo A, Ribero S, Puig S, Boada A, Paradela S, Moreno-Ramírez D, Cañueto J, de Unamuno B, Brinca A, Descalzo-Gallego MA, Osella-Abate S, Cassoni P, Carrera C, Vidal-Sicart S, Bennássar A, Rull R, Alos L, Requena C, Bolumar I, Traves V, Pla Á, Fernández-Orland A, Jaka A, Fernández-Figueres MT, Hilari JM, Giménez-Xavier P, Vieira R, Botella-Estrada R, Román-Curto C, Ferrándiz L, Iglesias-Pena N, Ferrándiz C, Malvehy J, Quaglino P, Nagore E, SENTIMEL group.
    Cancer Med; 2019 Aug; 8(9):4235-4244. PubMed ID: 31215168
    [Abstract] [Full Text] [Related]

  • 24. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
    Shields CL, Shields JA, Gündüz K, Cater J, Mercado GV, Gross N, Lally B.
    Arch Ophthalmol; 2000 Nov; 118(11):1497-507. PubMed ID: 11074806
    [Abstract] [Full Text] [Related]

  • 25. Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts.
    Isaksson K, Nielsen K, Mikiver R, Nieweg OE, Scolyer RA, Thompson JF, Ingvar C.
    J Surg Oncol; 2018 Sep; 118(4):599-605. PubMed ID: 30196533
    [Abstract] [Full Text] [Related]

  • 26. Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma.
    Yamamoto M, Fisher KJ, Wong JY, Koscso JM, Konstantinovic MA, Govsyeyev N, Messina JL, Sarnaik AA, Cruse CW, Gonzalez RJ, Sondak VK, Zager JS.
    Cancer; 2015 May 15; 121(10):1628-36. PubMed ID: 25677366
    [Abstract] [Full Text] [Related]

  • 27. Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients.
    Gambichler T, Scholl L, Bechara FG, Stockfleth E, Stücker M.
    Eur J Surg Oncol; 2016 Sep 15; 42(9):1420-6. PubMed ID: 27160354
    [Abstract] [Full Text] [Related]

  • 28. Iris Melanoma Outcomes Based on the American Joint Committee on Cancer Classification (Eighth Edition) in 432 Patients.
    Shields CL, Di Nicola M, Bekerman VP, Kaliki S, Alarcon C, Fulco E, Shields JA.
    Ophthalmology; 2018 Jun 15; 125(6):913-923. PubMed ID: 29342436
    [Abstract] [Full Text] [Related]

  • 29. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME, Bhutiani N, Farmer RW, Stromberg AJ, Martin RC, Quillo AR, McMasters KM, Scoggins CR.
    Surgery; 2016 May 15; 159(5):1412-21. PubMed ID: 26775577
    [Abstract] [Full Text] [Related]

  • 30. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
    Speijers MJ, Bastiaannet E, Sloot S, Suurmeijer AJ, Hoekstra HJ.
    Ann Surg Oncol; 2015 Sep 15; 22(9):2978-87. PubMed ID: 25605514
    [Abstract] [Full Text] [Related]

  • 31. Association of T and N Categories of the American Joint Commission on Cancer, 8th Edition, With Metastasis and Survival in Patients With Orbital Sarcoma.
    Sa HS, Rubin ML, Ning J, Li W, Tetzlaff MT, McGovern SL, Paulino AC, Herzog CE, Gill JB, Esmaeli B.
    JAMA Ophthalmol; 2020 Apr 01; 138(4):374-381. PubMed ID: 32105303
    [Abstract] [Full Text] [Related]

  • 32. Small and Isolated Immunohistochemistry-positive Cells in Melanoma Sentinel Lymph Nodes Are Associated With Disease-specific and Recurrence-free Survival Comparable to that of Sentinel Lymph Nodes Negative for Melanoma.
    LeBlanc RE, Barton DT, Li Z, Angeles CV, Ernstoff MS, Bagley E, Wimmer D, Wong SL, Barth RJ, Shirai K, Yan S.
    Am J Surg Pathol; 2019 Jun 01; 43(6):755-765. PubMed ID: 31091203
    [Abstract] [Full Text] [Related]

  • 33. Breslow thickness, clark index and ulceration are associated with sentinel lymph node metastasis in melanoma patients: a cohort analysis of 612 patients.
    Munsch C, Lauwers-Cances V, Lamant L, Gentil C, Rochaix P, Garrido I, Lopez R, Chevreau C, Paul C, Meyer N.
    Dermatology; 2014 Jun 01; 229(3):183-9. PubMed ID: 25171688
    [Abstract] [Full Text] [Related]

  • 34. Desmoplastic melanoma: is there a role for sentinel lymph node biopsy?
    Han D, Zager JS, Yu D, Zhao X, Walls B, Marzban SS, Rao NG, Sondak VK, Messina JL.
    Ann Surg Oncol; 2013 Jul 01; 20(7):2345-51. PubMed ID: 23389470
    [Abstract] [Full Text] [Related]

  • 35. Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients.
    Rousseau DL, Ross MI, Johnson MM, Prieto VG, Lee JE, Mansfield PF, Gershenwald JE.
    Ann Surg Oncol; 2003 Jun 01; 10(5):569-74. PubMed ID: 12794025
    [Abstract] [Full Text] [Related]

  • 36. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
    Murali R, Haydu LE, Quinn MJ, Saw RP, Shannon K, Spillane AJ, Stretch JR, Thompson JF, Scolyer RA.
    Ann Surg; 2012 Jan 01; 255(1):128-33. PubMed ID: 21975320
    [Abstract] [Full Text] [Related]

  • 37. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS, Haddad F, Messina J, Cantor AB, Fitzmorris K, Reintgen DS, Fenske NA, Glass LF.
    J Am Acad Dermatol; 2001 May 01; 44(5):762-6. PubMed ID: 11312421
    [Abstract] [Full Text] [Related]

  • 38. Factors affecting recurrence and metastasis in conjunctival melanoma.
    Çalış Karanfil F, Gündüz AK, Gündüz ÖÖ, Özalp Ateş FS.
    Int Ophthalmol; 2023 Nov 01; 43(11):4203-4215. PubMed ID: 37639080
    [Abstract] [Full Text] [Related]

  • 39. Diversity of stage III melanoma in the era of sentinel lymph node biopsy.
    Egger ME, Callender GG, McMasters KM, Ross MI, Martin RC, Edwards MJ, Urist MM, Noyes RD, Sussman JJ, Reintgen DS, Stromberg AJ, Scoggins CR.
    Ann Surg Oncol; 2013 Mar 01; 20(3):956-63. PubMed ID: 23064795
    [Abstract] [Full Text] [Related]

  • 40. Patterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decades.
    Esmaeli B, Wang X, Youssef A, Gershenwald JE.
    Ophthalmology; 2001 Nov 01; 108(11):2101-5. PubMed ID: 11713086
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.